Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials

We assessed whether oral insulin slowed metabolic decline after 1 year of treatment in individuals at high risk for type 1 diabetes. Two oral insulin trials that did not show efficacy overall and had type 1 diabetes as the primary end point were analyzed: the Diabetes Prevention Trial–Type 1 (DPT-1)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sosenko, Jay M., Skyler, Jay S., Herold, Kevan C., Schatz, Desmond A., Haller, Michael J., Pugliese, Alberto, Cleves, Mario, Geyer, Susan, Rafkin, Lisa E., Matheson, Della, Palmer, Jerry P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372067/
https://www.ncbi.nlm.nih.gov/pubmed/32439823
http://dx.doi.org/10.2337/db20-0166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372067/
https://www.ncbi.nlm.nih.gov/pubmed/32439823
http://dx.doi.org/10.2337/db20-0166

Ejemplares similares